Gritstone bio (NASDAQ:GRTS – Get Free Report) will release its earnings data after the market closes on Thursday, May 9th. Analysts expect Gritstone bio to post earnings of ($0.30) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Gritstone bio (NASDAQ:GRTS – Get Free Report) last released its quarterly earnings results on Tuesday, March 5th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.10. Gritstone bio had a negative return on equity of 147.22% and a negative net margin of 847.24%. The firm had revenue of $10.38 million during the quarter, compared to analysts’ expectations of $4.80 million. On average, analysts expect Gritstone bio to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Gritstone bio Stock Up 5.0 %
Shares of NASDAQ:GRTS opened at $1.01 on Wednesday. The company has a 50 day moving average of $1.66 and a two-hundred day moving average of $1.88. Gritstone bio has a 52-week low of $0.67 and a 52-week high of $3.33. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $108.20 million, a price-to-earnings ratio of -0.84 and a beta of 0.64.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on GRTS
Gritstone bio Company Profile
Gritstone bio, Inc, a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors.
Featured Stories
- Five stocks we like better than Gritstone bio
- Want to Profit on the Downtrend? Downtrends, Explained.
- Garmin Navigates to New Highs Driven By Wearables Trend
- What Are Dividend Champions? How to Invest in the Champions
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What is the Shanghai Stock Exchange Composite Index?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Gritstone bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gritstone bio and related companies with MarketBeat.com's FREE daily email newsletter.